HealthpeakDOC.NValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 16, 2026, Healthpeak (DOC.N) trades at a P/E of 54.00x, P/B of 1.67x, P/S of 4.44x, and a dividend yield of 6.42%.
Longitudinal percentile comparison: P/E sits at the 70th percentile over the trailing 10Y window (vs. 46th percentile over 3Y); P/B sits at the 23rd percentile over the trailing 10Y window (vs. 60th percentile over 3Y); P/S sits at the 10th percentile over the trailing 10Y window (vs. 32nd percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 86th percentile within its industry and the 86th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 7.16%, ranking at the 90th percentile over the trailing 20Y window.
The P/E and P/B percentiles diverge here, differing by 47.3 points — relying on either metric alone could be misleading. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Breaking down the total shareholder yield: 6.42% comes from cash dividends, with an implied ~0.74% from buybacks — a fairly balanced mix of both channels. Healthpeak operates in the Finance, Insurance, And Real Estate sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: NYSE: DOC · DOC
Want the full picture on whether Healthpeak (DOC.N) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 54.00 | ||||||
| P/B (MRQ) | 1.67 | ||||||
| P/S (TTM) | 4.44 | ||||||
| Dividend Yield | 6.42% | ||||||
| Buyback + Div Yield | 7.16% |